Home / Stocks / ASND

ASND insider trading

Ascendis Pharma A/S — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$777k
Buys · last 90 days
1 · $493k
Most recent buy
2026-08-18

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-18BIENAIME JEAN JACQUES
Director
Bought2,000$246.33$493k
2026-06-02SMITH SCOTT THOMAS
EVP & Chief Financial Officer
Bought100$219.00$22k
2026-06-01BIENAIME JEAN JACQUES
Director
Bought500$223.12$112k
2026-06-01SMITH SCOTT THOMAS
EVP & Chief Financial Officer
Bought250$223.32$56k
2026-05-27BIENAIME JEAN JACQUES
Director
Bought400$237.81$95k
2026-05-12JENSEN FLEMMING STEEN
See Remarks
Sold19,460$238.49$4.6M

Most active insider buyers

InsiderRoleBuysTotal bought
BIENAIME JEAN JACQUESDirector3$699k
SMITH SCOTT THOMASEVP & Chief Financial Officer2$78k

See ASND on the chart

Every insider buy and sell for ASND plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.